RE:Unanswered QuestionsThere's not much of a percentage in selling all of one's shares, especially at these prices...best case, hang on this drug could still be worth something to a Pharma and they could get it "on the cheap...we could still fifth cents to one dollar down the road, especially if we learn more that still hasn't been vetted. Of,interest is ALL the IP went to Zenith and we all still have a position.
As Teddy Rosevelt once said "it isn't the critic that counts..it's the person in the arena who at least won't be with those cold and timid souls that have never known victory or defeat". We're down but not out ...we'll all move on and keep the faith.